Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults.

Cox, Lynne S; Bellantuono, Ilaria; Lord, Janet M; Sapey, Elizabeth; Mannick, Joan B; Partridge, Linda; Gordon, Adam L; Steves, Claire J; Witham, Miles D

Cox, Lynne S; Bellantuono, Ilaria; Lord, Janet M; Sapey, Elizabeth; Mannick, Joan B; Partridge, Linda; Gordon, Adam L; Steves, Claire J; Witham, Miles D.

Afiliación

Cox LS; Department of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Bellantuono I; Healthy Lifespan Institute, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK.
Lord JM; MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Sapey E; PIONEER HDR-UK Hub in Acute Care, University of Birmingham, Birmingham, UK.
Mannick JB; NIHR/Wellcome Trust Birmingham Clinical Research Facility and Acute and Respiratory Medicine, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.
Partridge L; resTORbio, Boston, MA, USA.
Gordon AL; Max Planck Institute for Biology of Ageing, Cologne, Germany.
Steves CJ; Institute of Healthy Ageing and GEE, UCL, London, UK.
Witham MD; University of Nottingham, Nottingham, UK.

Lancet Healthy Longev ; 1(2): e55-e57, 2020 11.

Article en En | MEDLINE | ID: mdl-33521768

Asunto(s)

COVID-19; Inmunosenescencia; Vacunas; Anciano; Humanos; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / Inmunosenescencia / COVID-19 Límite: Aged / Humans Idioma: En Revista: Lancet Healthy Longev Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google